Book ChapterDOI
Pro-IL-1β Processing is an Essential Step in the Autocrine Regulation of Acute Myeloid Leukaemic Cell Growth
Stanislava Stosic-Grujicic,Nadežda Basara,Charles A. Dinarello +2 more
- pp 413-419
TLDR
The study shows that autonomous growth of AML cells is inhibited by antisense oligonucleotide to IL-1β converting enzyme and by IL- 1RA, and suggests that pro-IL-1 β processing is an essential step in the regulation ofAML cell growth.Abstract:
Publisher Summary This chapter presents a study on pro-1L-1β processing in the autocrine regulation of acute myeloid leukaemic (AML) cell growth. For this study, leukaemia cells of 19 randomly selected AML patients were obtained at diagnosis from bone marrow (BM) and peripheral blood (PB) samples. Low-density leukaemia cells were prepared by using the Ficoll–Hypaque density gradient, and they were grown continuously in the presence of recombinant human IL-1RA, or phosphorothioate-derived 16-mer antisense oligonucleotide for human IL-1β converting enzyme CCT-TGT-CGG-CCA-TGG-C. The effects of the agents on AML cell growth were assessed by using two complementary systems: colony formation (CFU-AML) and AML cell proliferation. Both BM-derived and PB-derived AML cells displayed autonomous growth. Spontaneous cell proliferation varied, as well as CFU-AML colony formation, and did not correlate with the type of AML according to the FAB criteria. The study shows that autonomous growth of AML cellsis inhibited by antisense oligonucleotide to IL-1β converting enzyme and by IL-1RA. IL-1 blockade affected AML cell proliferation as well as AML cell progenitors. Since the inhibitory effect of antisense ICE oligonucleotide was more efficient when compared to the effect of IL-1RA, the results suggest that pro-IL-1β processing is an essential step in the regulation of AML cell growth.read more
References
More filters
Journal ArticleDOI
Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia: A Report of the French-American-British Cooperative Group
John M. Bennett,Daniel Catovsky,Marie T. Daniel,George Flandrin,David A. G. Galton,Harvey R. Gralnick,C. Sultan +6 more
TL;DR: The first proposals for the morphologic classification of the acute leukemias by the French-American-British (FAB) group were put forward in the hope that they might serve as a basis for future studies.
Journal ArticleDOI
Interleukin-1 and interleukin-1 antagonism.
TL;DR: The recent cloning of a naturally occurring IL-1 receptor antagonist (IL-1ra) has opened new experimental and clinical approaches and reduced the severity of diseases such as hemodynamic shock, lethal sepsis, inflammatory bowel disease, experimental arthritis, and the spontaneous proliferation of human leukemic cells.
Journal ArticleDOI
Molecular cloning of the interleukin-1 beta converting enzyme
Douglas P. Cerretti,Carl J. Kozlosky,Bruce Mosley,Nicole Nelson,Kirk P. Van Ness,Teresa A. Greenstreet,Carl J. March,Shirley R. Kronheim,Teresa Druck,Linda A. Cannizzaro,Kay Huebner,Roy A. Black +11 more
TL;DR: A complementary DNA encoding a protease that carries out this cleavage has been cloned in this paper, and the gene encoding the protease was mapped to chromosomal band 11q23, a site frequently involved in rearrangement in human cancers.
Journal ArticleDOI
Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme.
TL;DR: Overexpression of Nedd2 in cultured fibroblast and neuroblastoma cells resulted in cell death by apoptosis, which was suppressed by the expression of the human bcl-2 gene, indicating that Nedd 2 is functionally similar to the ced-3 gene in C. elegans.
Journal ArticleDOI
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
Donna Rill,Donna Rill,Victor M. Santana,Victor M. Santana,W. Mark Roberts,W. Mark Roberts,Terri Nilson,Terri Nilson,Laura C. Bowman,Laura C. Bowman,Robert A. Krance,Robert A. Krance,Helen E. Heslop,Helen E. Heslop,Robert C. Moen,Robert C. Moen,James N. Ihle,James N. Ihle,Malcolm K. Brenner +18 more
TL;DR: The marker-gene technique described should permit evaluation of the mechanisms of relapse and the efficacy of purging in patients receiving autologous marrow transplantation for other solid tumors that infiltrate the marrow.